Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.
Stem Cells Transl Med
; 12(10): 631-650, 2023 10 05.
Article
in En
| MEDLINE
| ID: mdl-37713598
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinitis Pigmentosa
/
Wharton Jelly
/
Mesenchymal Stem Cells
Limits:
Humans
Language:
En
Journal:
Stem Cells Transl Med
Year:
2023
Document type:
Article
Country of publication:
United kingdom